340 related articles for article (PubMed ID: 31453052)
1. Safety Assessment of Nanomaterials to Eyes: An Important but Neglected Issue.
Zhu S; Gong L; Li Y; Xu H; Gu Z; Zhao Y
Adv Sci (Weinh); 2019 Aug; 6(16):1802289. PubMed ID: 31453052
[TBL] [Abstract][Full Text] [Related]
2. Dermal and ocular irritation and skin sensitization studies of fullerene C60 nanoparticles.
Ema M; Matsuda A; Kobayashi N; Naya M; Nakanishi J
Cutan Ocul Toxicol; 2013 Jun; 32(2):128-34. PubMed ID: 23050631
[TBL] [Abstract][Full Text] [Related]
3. Nanomaterials and nanoparticles: sources and toxicity.
Buzea C; Pacheco II; Robbie K
Biointerphases; 2007 Dec; 2(4):MR17-71. PubMed ID: 20419892
[TBL] [Abstract][Full Text] [Related]
4. Review of the effects of manufactured nanoparticles on mammalian target organs.
Wu T; Tang M
J Appl Toxicol; 2018 Jan; 38(1):25-40. PubMed ID: 28799656
[TBL] [Abstract][Full Text] [Related]
5. Nanomaterials-induced toxicity on cardiac myocytes and tissues, and emerging toxicity assessment techniques.
Cheng Y; Chen Z; Yang S; Liu T; Yin L; Pu Y; Liang G
Sci Total Environ; 2021 Dec; 800():149584. PubMed ID: 34399324
[TBL] [Abstract][Full Text] [Related]
6. Fate and risks of nanomaterials in aquatic and terrestrial environments.
Batley GE; Kirby JK; McLaughlin MJ
Acc Chem Res; 2013 Mar; 46(3):854-62. PubMed ID: 22759090
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular toxic effects of nanoparticles and corresponding molecular mechanisms.
Huang C; Liu X; Wu Q; Cao J; Zhu X; Wang X; Song Y
Environ Pollut; 2024 Jun; 356():124360. PubMed ID: 38871171
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of Nanoparticles on the Reproductive System in Animal Models: A Review.
Brohi RD; Wang L; Talpur HS; Wu D; Khan FA; Bhattarai D; Rehman ZU; Farmanullah F; Huo LJ
Front Pharmacol; 2017; 8():606. PubMed ID: 28928662
[TBL] [Abstract][Full Text] [Related]
9. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
[TBL] [Abstract][Full Text] [Related]
10. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies.
Klein CL; Wiench K; Wiemann M; Ma-Hock L; van Ravenzwaay B; Landsiedel R
Arch Toxicol; 2012 Jul; 86(7):1137-51. PubMed ID: 22532024
[TBL] [Abstract][Full Text] [Related]
11. Ocular toxicity of reduced graphene oxide or graphene oxide exposure in mouse eyes.
An W; Zhang Y; Zhang X; Li K; Kang Y; Akhtar S; Sha X; Gao L
Exp Eye Res; 2018 Sep; 174():59-69. PubMed ID: 29803558
[TBL] [Abstract][Full Text] [Related]
12. Metallic Engineered Nanomaterials and Ocular Toxicity: A Current Perspective.
Cosert KM; Kim S; Jalilian I; Chang M; Gates BL; Pinkerton KE; Van Winkle LS; Raghunathan VK; Leonard BC; Thomasy SM
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631569
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and mechanism of mesoporous silica nanoparticles in eyes.
Chen X; Zhu S; Hu X; Sun D; Yang J; Yang C; Wu W; Li Y; Gu X; Li M; Liu B; Ge L; Gu Z; Xu H
Nanoscale; 2020 Jul; 12(25):13637-13653. PubMed ID: 32567638
[TBL] [Abstract][Full Text] [Related]
14. Nanoexposure, unusual diseases, and new health and safety concerns.
Song Y; Tang S
ScientificWorldJournal; 2011; 11():1821-8. PubMed ID: 22125440
[TBL] [Abstract][Full Text] [Related]
15. Graphene Family Nanomaterials in Ocular Applications: Physicochemical Properties and Toxicity.
Borandeh S; Alimardani V; Abolmaali SS; Seppälä J
Chem Res Toxicol; 2021 Jun; 34(6):1386-1402. PubMed ID: 34041903
[TBL] [Abstract][Full Text] [Related]
16. Fabricated nanoparticles: current status and potential phytotoxic threats.
Yadav T; Mungray AA; Mungray AK
Rev Environ Contam Toxicol; 2014; 230():83-110. PubMed ID: 24609519
[TBL] [Abstract][Full Text] [Related]
17. Safety and toxicity of nanomaterials for ocular drug delivery applications.
Mehra NK; Cai D; Kuo L; Hein T; Palakurthi S
Nanotoxicology; 2016 Sep; 10(7):836-60. PubMed ID: 27027670
[TBL] [Abstract][Full Text] [Related]
18. Advances in endocrine toxicity of nanomaterials and mechanism in hormone secretion disorders.
Yao Y; Tang M
J Appl Toxicol; 2022 Jul; 42(7):1098-1120. PubMed ID: 34935166
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle translocation and multi-organ toxicity: A particularly small problem.
Raftis JB; Miller MR
Nano Today; 2019 Jun; 26():8-12. PubMed ID: 31217806
[TBL] [Abstract][Full Text] [Related]
20. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.
Warheit DB; Borm PJ; Hennes C; Lademann J
Inhal Toxicol; 2007 Jun; 19(8):631-43. PubMed ID: 17510836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
